SCHEMBL7535134

SCHEMBL7535134

CCc1noc(C(=NOC)c2ccccc2COc2cc(C)ccc2C)n1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ MAPT P10636 4/20 0.40
▸ RAB9A P51151 8/20 0.36
▸ NPC1 O15118 7/20 0.36
▸ SMN1; SMN2 Q16637 3/20 0.36
▸ TSHR P16473 3/20 0.35
▸ MAPK1 P28482 3/20 0.35
▸ L3MBTL1 Q9Y468 2/20 0.35
▸ LMNA P02545 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ CASP3 P42574 1/20 0.35
▸ SENP8 Q96LD8 1/20 0.35
▸ SENP7 Q9BQF6 1/20 0.35
▸ SENP6 Q9GZR1 1/20 0.35
▸ TDP1 Q9NUW8 2/20 0.34
▸ MEN1 O00255 1/20 0.33
▸ AKR1C3 P42330 1/20 0.33
▸ SGMS2 Q8NHU3 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7535896 0.81 MAPT (0.40) KMT2AALDH1A1MAPTRAB9ANPC1
SCHEMBL7538368 0.80 MAPT (0.36) KMT2AALDH1A1MAPTRAB9ANPC1
SCHEMBL7535399 0.79 RAB9A (0.39) KMT2AALDH1A1MAPTRAB9ANPC1
SCHEMBL7541677 0.76 ALDH1A1 (0.38) KMT2AALDH1A1MAPTRAB9ANPC1
SCHEMBL7535938 0.74 SMN1; SMN2 (0.42) KMT2AALDH1A1MAPTRAB9ANPC1
SCHEMBL7535933 0.74 SMN1; SMN2 (0.42) KMT2AALDH1A1MAPTRAB9ANPC1
SCHEMBL7537475 0.74 SMN1; SMN2 (0.38) KMT2AALDH1A1MAPTRAB9ANPC1
SCHEMBL7535888 0.73 MAPT (0.39) KMT2AALDH1A1MAPTRAB9ANPC1
SCHEMBL7537355 0.73 MAPT (0.39) KMT2AALDH1A1MAPTRAB9ANPC1
SCHEMBL7536274 0.73 SMN1; SMN2 (0.36) KMT2AALDH1A1MAPTRAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6362212-B1 POTENT FUNGICIDAL ACTIVITY SHIONOGI & COMPANY, LTD. (JP) 2002-03-26 — — US disclosed
US-20020032227-A1 Oxime derivative and bactericide containing the same as active ingredient TAKASE AKIRA (JP) 2002-03-14 — — US disclosed
US-6268312-B1 FUNGICIDES SHIONOGI & CO., LTD. (JP) 2001-07-31 — — US disclosed
US-6048885-A FUNGICIDES SHIONOGI & CO., LTD. (JP) 2000-04-11 — — US disclosed
EP-0754684-A1 OXIME DERIVATIVE AND BACTERICIDE CONTAINING THE SAME AS ACTIVE INGREDIENT SHIONOGI & CO., LTD. (JP) 1997-01-22 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020032227-A1 Oxime derivative and bactericide containing the same as active ingredient MSMO1, O60361, CBR1 KMT2A 1852/4885ALDH1A1 1113/4885MAPT 4733/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback